Paulex Bio Receives NIH Fast-Track Grant to Advance Beta Cell Regeneration Therapy of PAL-119

Clearmind Medicine Among Top Biopharma Companies Invited to join Washington DC, Psychedelic Summit

Rail Vision Successfully Completes U.S. Rail Industry Testing Phase Under the Association of American Railroads’ Technology Roadmap Program

Allucent Appoints Chief Medical Officer and Infectious Disease Therapeutic Strategy Head

Quantum Cyber Expands and Secures Exclusive Quantum Photonic Array License, Extending Its Quantum Layer Across Air, Surface and Subsea...

Pyxus Announces the Commencement of Exchange Offer and Consent Solicitation With Respect to its 8.50% Senior Secured Notes due 2027

Ardelyx to Participate at the Jefferies Global Healthcare Conference in London

Richey May Releases Executive Guide to More Strategic Mortgage Servicing Decisions

BrainsWay Reports Third Quarter 2026 Financial Results and Operational Highlights

Cortechs.ai and Subtle Medical Partner to Deliver Faster MRI with Standardized Quantitative Neuroimaging

Habit & Co. Welcomes Chef and Creator Olivia Tiedemann as its Third Culinary Resident

Nearwater Capital Appoints Amar Kuchinad as President

Kalaris Reports Third Quarter 2026 Financial Results and Provides Business Update

Park Place Financial and IP Private Wealth Unite to Build a Stronger Regional Presence with Greater Continuity and Scale

GoGuardian Launches GoGuardian Visitor, Delivering the Most Complete Visitor Management Solution in K-12

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Exagen Inc. Reports Third Quarter 2026 Financial Results

XCharge Reports 61% Year-over-Year Revenue Growth in Third Quarter 2026

Cerenome Appoints Director Ron Andrews as Chief Business Officer

Xilio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Pipeline and Business Updates